Factors Associated With Viral Load Suppression Among Adolescents and Young Adults Living With HIV on ART in Rwanda: Data From Rwanda HIV Case‐Based Surveillance, 2019–2025
Authors:
- Gallican N. RwibasiraGRGallican N. Rwibasira
- Jean Claude KwizeraJKJean Claude Kwizera
- Steven KareraSKSteven Karera
- Tafadzwa DzinamariraTafadzwa Dzinamarira
- Charles HolmesCHCharles Holmes
- Ayman AhmedAAAyman Ahmed
- Albert TuyishimeATAlbert Tuyishime
- Eric RemeraEREric Remera
- Daniel Henry ParisDaniel Henry Paris
- Tracy R. GlassTGTracy R. Glass
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1) , 5304043
Abstract
Background: Adolescents and young adults living with HIV (AYALHIV) in sub‐Saharan Africa have lower viral load (VL) suppression (VLS) rates than older adults. Rwanda lacks national‐level evidence on predictors of VLS in this age group. This study assessed demographic and clinical determinants of VLS among AYALHIV aged 15–24 years on antiretroviral therapy (ART), using national case‐based surveillance (CBS) data. Methods: We conducted a retrospective cohort analysis of AYALHIV enrolled in Rwanda’s CBS system who initiated ART between January 2019 and December 2025 and had a documented VL at least six months after ART initiation. The primary outcome, VLS, was defined as VL ≤ 1000 copies/mL. Modified Poisson regression with robust, facility‐clustered standard errors was used to estimate prevalence ratios (PRs); missing covariate data were addressed using multiple imputation ( m = 20), pooled using Rubin’s rules. Results: A total of 4140 participants across 458 health facilities were included. Most were female (88%) and aged 20–24 years (90.7%); 91.6% were initiated on a dolutegravir‐based regimen, 98.7% demonstrated good adherence, and overall, 96.1% achieved VLS. In multivariable analysis, good adherence was the only factor independently associated with VLS, corresponding to a 70% higher prevalence of suppression relative to bad/moderate adherence (adjusted PR = 1.70; 95% CI: 1.33–2.19; p < 0.001). Conclusion: VLS among AYALHIV aged 15–24 years engaged in Rwanda’s HIV care program is high, exceeding the UNAIDS 95% target. Country HIV programs should prioritize adherence‐focused interventions and proactively address underlying barriers to adherence in order to sustain optimal treatment outcomes in this population.Keywords
This publication has 37 references indexed in Scilit:
- Magnitude and characteristics of unsuppressed HIV viral load in children and adolescents on antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysisThe Lancet HIV, 2025
- Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With HIV on Dolutegravir in Europe and ThailandClinical Infectious Diseases, 2025
- Prevalence and factors associated with viral non‐suppression in people living with HIV receiving antiretroviral therapy in sub‐Saharan Africa: A systematic review and meta‐analysisReviews in Medical Virology, 2024
- Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern AfricaThe Pediatric Infectious Disease Journal, 2023
- Forty years of investment in HIV research: progress towards ending the HIV pandemic and preparation for future pandemicsJournal of the International AIDS Society, 2022
- Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenNew England Journal of Medicine, 2021
- Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trialThe Lancet, 2021
- High levels of viral load monitoring and viral suppression under Treat All in Rwanda – a cross‐sectional studyJournal of the International AIDS Society, 2020
- Patterns of detectable viral load in a cohort of HIV‐positive adolescents on antiretroviral therapy in South AfricaJournal of the International AIDS Society, 2020
- The Adolescent and Young Adult HIV Cascade of Care in the United States: Exaggerated Health DisparitiesAIDS Patient Care and STDs, 2014